(Q34317221)

1 August 2017

1 reference

title

Folate supplementation during methotrexate treatment of patients with rheumatoid arthritis. An update and proposals for guidelines (English)

1 reference

1 August 2017

1 reference

1 reference

1 reference

Endresen GK

1

1 reference

1 August 2017

Husby G

series ordinal

2

1 reference

1 August 2017

publication date

1 January 2001

1 reference

Scandinavian Journal of Rheumatology

1 August 2017

published in

1 reference

1 August 2017

volume

30

1 reference

1 August 2017

issue

3

1 reference

1 August 2017

page(s)

129-134

1 reference

Methotrexate use in rheumatoid arthritis

1 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F030097401300162888

Meta-analysis of treatment termination rates among rheumatoid arthritis patients receiving disease-modifying anti-rheumatic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F030097401300162888

Triple therapy with methotrexate, sulfasalazine, and hydroxychloroquine in patients with rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F030097401300162888

Low-dose methotrexate in rheumatic diseases--efficacy, side effects, and risk factors for side effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F030097401300162888

Long-term prospective study of the use of methotrexate in the treatment of rheumatoid arthritis. Update after a mean of 90 months

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F030097401300162888

Folate supplementation and methotrexate

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F030097401300162888

Methotrexate in rheumatoid arthritis. An update

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F030097401300162888

Methotrexate in rheumatoid arthritis: an update with focus on mechanisms involved in toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F030097401300162888

Molecular therapeutics. Methotrexate and its mechanism of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F030097401300162888

Pharmacology and pharmacokinetics of methotrexate in rheumatic disease. Practical issues in treatment and design

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F030097401300162888

The effect of folic acid supplementation on the toxicity of low-dose methotrexate in patients with rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F030097401300162888

The use of folates concomitantly with low-dose pulse methotrexate

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F030097401300162888

The remarkable spectrum of methotrexate toxicities

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F030097401300162888

Elevated mean corpuscular volume as a predictor of hematologic toxicity due to methotrexate therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F030097401300162888

Evaluation of anemia. Getting the most out of the MCV, RDW, and other tests

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F030097401300162888

Methotrexate and emerging therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F030097401300162888

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F030097401300162888

Methotrexate metabolism analysis in blood and liver of rheumatoid arthritis patients. Association with hepatic folate deficiency and formation of polyglutamates

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F030097401300162888

The effects of leucovorin (folinic acid) on methotrexate therapy in rheumatoid arthritis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F030097401300162888

Low-dose methotrexate with leucovorin (folinic acid) in the management of rheumatoid arthritis. Results of a multicenter randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F030097401300162888

Folate supplementation in methotrexate-treated rheumatoid arthritis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F030097401300162888

Supplementation with folic acid during methotrexate therapy for rheumatoid arthritis. A double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F030097401300162888

Treatment of gastrointestinal symptoms associated with methotrexate therapy for psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F030097401300162888

Elevation of serum hepatic aminotransferases during treatment of rheumatoid arthritis with low-dose methotrexate. Risk factors and response to folic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F030097401300162888

Improved classification of anemias by MCV and RDW

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F030097401300162888

10.1080/030097401300162888

21 January 2018

Identifiers

DOI

1 reference

1 August 2017

1 reference